Development of Vaccine Formulations Effective Against NIAID Priority Pathogens | Federal Compass

Free Market Report: Trends & Observations
Development of Vaccine Formulations Effective Against NIAID Priority Pathogens


Prepare yourself for competition by understanding federal market trends. Is this the right pursuit for my organization? How is the government buying my product and services? Is there an upcoming recompete for future work?


Contracting Agency/Office
Health and Human Services » National Institutes of Health » National Institute of Allergy and Infectious Diseases
NAICS
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Competition Set-Aside Type
NONE

Award Type
Definitive Contract
Award Date
07/23/2014
Expiration Date
No. of Awards
4
No. of Offers
7

Obligations by Fiscal Year

prime obligations by fiscal year

Download the Full Report Today
Trends & Observations: Development of Vaccine Formulations Effective Against NIAID Priority Pathogens

The full contract vehicle assessment includes:
Preference Program Trends
Set Aside Preference
Key Buyers
Buying Trends & Activity
Funding Account Health
Task Order Activity
Small Business Trends
Contractor Performance
Potential Recompete Opportunities

If you do business with the Federal Government, you need Federal Compass.

We are a public sector market intelligence and solutions platform for government contracting.

Contracting Resources